Molecular diversity of Proteus mirabilis isolates producing extended-spectrum β-lactamases in a French university hospital
Open Access
- 1 May 2005
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (5) , 395-401
- https://doi.org/10.1111/j.1469-0691.2005.01147.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized PatientsJournal of Clinical Microbiology, 2004
- Nosocomial Outbreak of Infections by Proteus mirabilis That Produces Extended-Spectrum CTX-M-2 Type β-LactamaseJournal of Clinical Microbiology, 2003
- Escherichia coli y Klebsiella pneumoniae productores de betalactamasas de espectro extendido en hospitales españoles (Proyecto GEIH-BLEE 2000)Enfermedades Infecciosas y Microbiología Clínica, 2003
- Molecular Characterization of Extended-Spectrum β-Lactamases Produced by Nosocomial Isolates of Enterobacteriaceae from an Italian Nationwide SurveyJournal of Clinical Microbiology, 2002
- Prevalence of β-Lactamases among 1,072 Clinical Strains of Proteus mirabilis : a 2-Year Survey in a French HospitalAntimicrobial Agents and Chemotherapy, 2000
- Diversity of TEM Mutants in Proteus mirabilisAntimicrobial Agents and Chemotherapy, 1999
- Potential virulence factors of Proteus bacilli.Microbiology and Molecular Biology Reviews, 1997
- Extended-spectrum β-lactamase in Proteus mirabilisJournal of Antimicrobial Chemotherapy, 1994
- Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitalsJournal of Antimicrobial Chemotherapy, 1993